These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 24313671
1. Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS-active derivative of valproic acid with low teratogenic potential. Shekh-Ahmad T, Hen N, Yagen B, McDonough JH, Finnell RH, Wlodarczyk BJ, Bialer M. Epilepsia; 2014 Feb; 55(2):353-61. PubMed ID: 24313671 [Abstract] [Full Text] [Related]
2. The potential of sec-butylpropylacetamide (SPD) and valnoctamide and their individual stereoisomers in status epilepticus. Shekh-Ahmad T, Mawasi H, McDonough JH, Yagen B, Bialer M. Epilepsy Behav; 2015 Aug; 49():298-302. PubMed ID: 25979572 [Abstract] [Full Text] [Related]
3. Evaluation of the antiallodynic, teratogenic and pharmacokinetic profile of stereoisomers of valnoctamide, an amide derivative of a chiral isomer of valproic acid. Kaufmann D, Yagen B, Minert A, Wlodarczyk B, Finnell RH, Schurig V, Devor M, Bialer M. Neuropharmacology; 2010 Jun; 58(8):1228-36. PubMed ID: 20230843 [Abstract] [Full Text] [Related]
10. Design and pharmacological activity of glycinamide and N-methoxy amide derivatives of analogs and constitutional isomers of valproic acid. Pessah N, Yagen B, Hen N, Shimshoni JA, Wlodarczyk B, Finnell RH, Bialer M. Epilepsy Behav; 2011 Nov; 22(3):461-8. PubMed ID: 21959082 [Abstract] [Full Text] [Related]
11. Anticonvulsant profile and teratogenicity of 3,3-dimethylbutanoylurea: a potential for a second generation drug to valproic acid. Shimshoni JA, Yagen B, Pessah N, Wlodarczyk B, Finnell RH, Bialer M. Epilepsia; 2008 Jul; 49(7):1202-12. PubMed ID: 18435754 [Abstract] [Full Text] [Related]
12. sec-Butyl-propylacetamide (SPD) and two of its stereoisomers rapidly terminate paraoxon-induced status epilepticus in rats. Bar-Klein G, Swissa E, Kamintsky L, Shekh-Ahmad T, Saar-Ashkenazy R, Hubary Y, Shrot S, Stetlander L, Eisenkraft A, Friedman A, Bialer M. Epilepsia; 2014 Dec; 55(12):1953-8. PubMed ID: 25377630 [Abstract] [Full Text] [Related]
15. Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice. Okada A, Noyori H, Yagen B, Shimshoni JA, Bialer M, Fujiwara M. Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):394-401. PubMed ID: 19830722 [Abstract] [Full Text] [Related]
17. Derivatives of valproic acid are active against pentetrazol-induced seizures in immature rats. Mareš P, Kubová H, Hen N, Yagen B, Bialer M. Epilepsy Res; 2013 Sep; 106(1-2):64-73. PubMed ID: 23815889 [Abstract] [Full Text] [Related]
19. Stereoselective pharmacokinetic analysis of valnoctamide, a CNS-active chiral amide analogue of valproic acid, in dogs, rats, and mice. Spiegelstein O, Yagen B, Bennett GD, Finnell RH, Blotnik S, Bialer M. Ther Drug Monit; 2000 Oct; 22(5):574-81. PubMed ID: 11034263 [Abstract] [Full Text] [Related]
20. Amidic modification of valproic acid reduces skeletal teratogenicity in mice. Okada A, Kurihara H, Aoki Y, Bialer M, Fujiwara M. Birth Defects Res B Dev Reprod Toxicol; 2004 Feb; 71(1):47-53. PubMed ID: 14991910 [Abstract] [Full Text] [Related] Page: [Next] [New Search]